3-Isoxazolecarboxamide, 5-(4-fluorophenyl)-N-[3-(1H-imidazol-1-yl)propyl]- manufacturers
|
| | 3-Isoxazolecarboxamide, 5-(4-fluorophenyl)-N-[3-(1H-imidazol-1-yl)propyl]- Basic information |
| | 3-Isoxazolecarboxamide, 5-(4-fluorophenyl)-N-[3-(1H-imidazol-1-yl)propyl]- Chemical Properties |
| Boiling point | 606.3±55.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | storage temp. | 4°C, protect from light | | solubility | DMSO : 125 mg/mL (397.70 mM; Need ultrasonic) | | form | Solid | | pka | 10.23±0.46(Predicted) | | color | Yellow to brown |
| | 3-Isoxazolecarboxamide, 5-(4-fluorophenyl)-N-[3-(1H-imidazol-1-yl)propyl]- Usage And Synthesis |
| Uses | Wnt/β-catenin agonist 4 (Derivative 83) is an agonist of Wnt that activates Wnt/β-catenin signal transmission[1]. | | References | [1] Jeong Woo Cho, et al. Isoxazole derivatives and use thereof. Patent WO2007078113A1. |
| | 3-Isoxazolecarboxamide, 5-(4-fluorophenyl)-N-[3-(1H-imidazol-1-yl)propyl]- Preparation Products And Raw materials |
|